


To provide capital growth and income.
| Name | % Net Assets | 
|---|---|
| Vodafone Group PLC | 6.7% | 
| GlaxoSmithKline PLC | 6.6% | 
| Royal Dutch Shell PLC (CL B) | 6.0% | 
| BP PLC | 5.1% | 
| British American Tobacco PLC | 4.9% | 
| AstraZeneca PLC | 4.7% | 
| Imperial Tobacco Group PLC | 4.4% | 
| National Grid PLC | 4.3% | 
| BG Group PLC | 4.2% | 
| HSBC Holdings PLC | 3.7% | 
| Key | % Net Assets | 
|---|---|
| 6.7% | |
| 6.6% | |
| 6.0% | |
| 5.1% | |
| 75.6% | 
| Date | n/a | 
|---|---|
| Bid | 0.00 | 
| Offer | 0.00 | 
| Currency | n/a | 
| Change | 0.00 | 
| % | n/a | 
| YTD change | 0.00 | 
| YTD % | n/a | 
| Fund Inception | 13/02/2004 | 
|---|---|
| Fund Manager | n/a | 
| TER | - | 
| Minimum Investment | |
|---|---|
| Initial | 500000 | 
| Additional | n/a | 
| Savings | n/a | 
| Charges | |
|---|---|
| Initial | n/a | 
| Annual Mang't | 2.00% | 
| Exit | n/a | 
| Name | % | 
|---|---|
| Standard deviation | 0.01 | 
| Sharpe ratio | 0.06 | 
You are here: research